Lamivudine FDA Link

A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.

Also Known As:

Epivir; 2',3' Dideoxy 3' thiacytidine; BCH-189; GR-109714X; GR109714X; Lamivudine, (2S-cis)-Isomer; BCH 189; BCH189; GR 109714X; Lamivudine, 3TC; 2',3'-Dideoxy-3'-thiacytidine; 2(1H)-Pyrimidinone, 4- amino- 1- (2- (hydroxymethyl)- 1,3- oxathiolan- 5- yl)- , (2R-cis)-; 3TC Lamivudine; Lamivudine, (+)-cis-; Lamivudine, (+-)-trans-

Pharmalogical Action Categories:

Anti-HIV Agents
Reverse Transcriptase Inhibitors

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 521
    - Pyrimidine Nucleosides: 50
      - Cytidine: 548
        Deoxycytidine: 310
        Zalcitabine: 278
        Lamivudine: 3645
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6937
  - Pyrimidine Nucleosides: 50
    - Cytidine: 548
      - Deoxycytidine: 310
        Zalcitabine: 278
        Lamivudine: 3645
  - Deoxyribonucleosides: 34
    - Deoxycytidine: 310
      - Zalcitabine: 278
        Lamivudine: 3645
    - Dideoxynucleosides: 27
      - Zalcitabine: 278
        Lamivudine: 3645

Andy Black Selected Research

Andy Black Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure